Establishes "End-Stage Kidney Disease Prevention and Innovation Act"; appropriates $10 million.
Introduced First Reading Assembly Referred to AHE
Email me when A 4924 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track A 4924. By continuing you agree to the Terms and Privacy Policy.
Legislative status
- Introduced
- In Committee
- Reported by Committee
- Floor Vote Scheduled
- Passed One Chamber
- Passed Both Chambers
- Sent to Executive
- Signed into Law
Summary
The bill directs the New Jersey Department of Health to set up Centers on Rare Kidney Disease Research and to fund them through grants and cooperative agreements. It also requires a statewide study of testing, prevention, precision medicine and treatment for rare kidney diseases, especially in underserved communities. $10 million from the General Fund is allocated, and the program runs for five years.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about A 4924
3 free questions a day, no accountHistory
- Introduced, Referred to Assembly Health Committee
Sponsors
- Stewart, Kenyatta · sponsor
- Kearney, Vincent M.
- Speight, Shanique
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when A 4924 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track A 4924 freeOr ask your AI assistant about A 4924 directly:
Add to Claude, ChatGPT or Cursor